General Information
BounceWatch is an independent company data service, not affiliated with Celcuity. To contact Celcuity, visit celcuity.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Celcuity compare?
A PDF of Celcuity and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Celcuity soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Celcuity on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Celcuity
Funding Rounds & Investors (13)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Debt | $62.00M | 1 | 30 May 2024 | |
| Post IPO Equity | $60.00M | 6 | 30 May 2024 | |
| Post IPO Equity | $50.00M | - |
|
18 Oct 2023 |
| Post IPO Debt | $20.00M | - |
|
12 Dec 2022 |
| Post IPO Equity | $100.00M | 6 | 16 May 2022 | |
| Post IPO Equity | $24.00M | - |
|
24 Feb 2021 |
| Post IPO Debt | $3.75K | - |
|
19 Oct 2019 |
| Post IPO Equity | $5.81K | - |
|
04 Nov 2018 |
| Convertible Note | $2.59M | - |
|
19 May 2017 |
| Convertible Note | $5.75M | - |
|
02 May 2017 |
Celcuity Alternatives & Competitors
View All AlternativesOvercoming Immunotherapy resistance
Delivering a cancer-free future
Advancing cancer treatment through innovative therapeutics targeting cell membranes.
FAQ About Celcuity
Source: BounceWatch company record for Celcuity, https://bouncewatch.com/company/celcuity, updated 31 December 2024. When citing, please name BounceWatch and link this page.